Prevalence of plasmid-mediated AmpC beta-lactamases in a Chinese university hospital from 2003 to 2005: first report of CMY-2-Type AmpC beta-lactamase resistance in China
about
Enhancing resistance to cephalosporins in class C beta-lactamases: impact of Gly214Glu in CMY-2.Chromosomally encoded blaCMY-2 located on a novel SXT/R391-related integrating conjugative element in a Proteus mirabilis clinical isolate.Laboratory surveillance for prospective plasmid-mediated AmpC beta-lactamases in the Kinki region of JapanOpposite effects of cefoperazone and ceftazidime on S‑ribosylhomocysteine lyase/autoinducer-2 quorum sensing and biofilm formation by an Escherichia coli clinical isolate.Increase in resistance to extended-spectrum cephalosporins in Salmonella isolated from retail chicken products in JapanIncA/C plasmid-mediated spread of CMY-2 in multidrug-resistant Escherichia coli from food animals in China.Extraintestinal Pathogenic Escherichia coli: A Combination of Virulence with Antibiotic ResistanceThe Beta Lactam Antibiotics as an Empirical Therapy in a Developing Country: An Update on Their Current Status and Recommendations to Counter the Resistance against ThemEvaluation of screening methods to detect plasmid-mediated AmpC in Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis.Multiresistant Enterobacteriaceae: new threat of an old problem.AmpC beta-lactamases.Emergence of CMY-2- and DHA-1-type AmpC β-lactamases in Enterobacter cloacae isolated from several hospitals of Qazvin and Tehran, Iran.Extraintestinal pathogenic Escherichia coli: an update on antimicrobial resistance, laboratory diagnosis and treatment.Multidrug-resistant Escherichia coli in Asia: epidemiology and management.Tackling antimicrobial resistance in lower urinary tract infections: treatment options.The direct anti-MRSA effect of emodin via damaging cell membrane.Antibiotic resistance in wastewater: occurrence and fate of Enterobacteriaceae producers of class A and class C β-lactamases.Distribution of ESBLs, AmpC β-lactamases and carbapenemases among Enterobacteriaceae isolates causing intra-abdominal and urinary tract infections in the Asia-Pacific region during 2008-14: results from the Study for Monitoring Antimicrobial ResistaEpidemiology and risk factors for infections due to AmpC β-lactamase-producing Escherichia coli.Increased frequency of integrons and β-lactamase-coding genes among extraintestinal Escherichia coli isolated with a 7-year interval.Integron-bearing Gram-negative bacteria in lake waters.Diversity of bla genes and low incidence of CTX-M in plasmid-mediated AmpC-producing Escherichia coli clinical isolates.Long-term dissemination of acquired AmpC β-lactamases among Klebsiella spp. and Escherichia coli in Portuguese clinical settings.Rapid rise of the ESBL and mcr-1 genes in Escherichia coli of chicken origin in China, 2008-2014.Evaluation of four phenotypic methods to detect plasmid-mediated AmpC β-lactamases in clinical isolates.The genetic background of antibiotic resistance among clinical uropathogenic Escherichia coli strains
P2860
Q33601560-E6CE7425-1C00-4B4C-9946-57B6F013D8ABQ34108605-161B7DF2-0E9C-4496-AD7C-F5E9D725C03FQ34120497-BED7B0C8-48F0-4747-94D8-944008F9A5F9Q34426876-B3C6EA6C-DDE7-4B6A-8A5E-DE3E5AE6817AQ35038811-132A58C9-5637-4A73-AFF3-C9C24282F2ACQ35166517-18F3A393-4502-4E4D-B19F-1345E0D28426Q35681590-39C2BE4C-7BB8-487F-A645-E61733AA2230Q37002208-D139C1BB-0CDE-44BC-BB46-81DF21D0B721Q37032817-8F7531F1-24A6-4F2B-818A-EA6C43E29A19Q37291349-C672E240-FBF7-4EE5-83BC-CA5FC7B3231CQ37366249-44772C79-ED73-451F-AC96-C93CEBD56972Q37477939-7EF5FAFC-F193-4551-BB01-DA8B2EEC7745Q38063968-1DBE3512-B38E-4D93-83CB-E8A5DCA7D997Q38389612-83A2FB43-0F44-46FA-83EB-B89586D1CB71Q38833839-DFF8BA38-B729-476B-85F7-E0C11404AD37Q39003873-5706283D-7A6F-4285-A03E-B2717FCBD2B9Q39092050-0B55EEAB-32B2-4B0D-AE29-DCC3FF0DE409Q40517201-0755CE3A-5434-4A01-8B96-4DF290EBE676Q41621778-D27CA19F-BE8C-4A66-A5D8-ADC2A35A96CEQ42426450-E11CDA91-B5EF-4D19-9697-95EBD018DCF6Q43167978-A1FBA8CB-0B7E-4F1B-A018-08E3FA7537BDQ44095874-4BA37103-14D9-4FC0-B350-6990A3ECF1A0Q46986700-8DE501CC-AA3E-4FA0-8C33-3D47727A009AQ52657330-548A6C7B-8EA2-48BB-B53F-5A4CEAAA8DB6Q54343580-D87DF2AE-F864-4C98-8010-68A1F3B2A1A2Q57930193-A2C237D6-6938-43E5-A1BF-F90146FA4289
P2860
Prevalence of plasmid-mediated AmpC beta-lactamases in a Chinese university hospital from 2003 to 2005: first report of CMY-2-Type AmpC beta-lactamase resistance in China
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Prevalence of plasmid-mediated ...... -lactamase resistance in China
@en
type
label
Prevalence of plasmid-mediated ...... -lactamase resistance in China
@en
prefLabel
Prevalence of plasmid-mediated ...... -lactamase resistance in China
@en
P2093
P2860
P356
P1476
Prevalence of plasmid-mediated ...... -lactamase resistance in China
@en
P2093
Jianqiang Wang
Xiaofei Jiang
Yanqun Jiang
P2860
P304
P356
10.1128/JCM.00073-07
P407
P577
2008-02-27T00:00:00Z